Weathering the storm: COVID-19 infection in patients with hematological malignancies / 浙江大学学报(英文版)(B辑:生物医学和生物技术)
Journal of Zhejiang University. Science. B
; (12): 921-939, 2020.
Article
em En
| WPRIM
| ID: wpr-880734
Biblioteca responsável:
WPRO
ABSTRACT
The coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Within a matter of months, this highly contagious novel virus has led to a global outbreak and is still spreading rapidly across continents. In patients with COVID-19, underlying chronic diseases and comorbidities are associated with dismal treatment outcomes. Owing to their immunosuppressive status, patients with hematological malignancies (HMs) are at an increased risk of infection and have a worse prognosis than patients without HMs. Accordingly, intensive attention should be paid to this cohort. In this review, we summarize and analyze specific clinical manifestations for patients with coexisting COVID-19 and HMs. Furthermore, we briefly describe customized management strategies and interventions for this susceptible cohort. This review is intended to guide clinical practice.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Fatores de Risco
/
Hospedeiro Imunocomprometido
/
Neoplasias Hematológicas
/
Gerenciamento Clínico
/
Diagnóstico Diferencial
/
COVID-19
/
Hospitalização
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Journal of Zhejiang University. Science. B
Ano de publicação:
2020
Tipo de documento:
Article